Financial Statements (unaudited)
ITEM 1. FINANCIAL STATEMENTS CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (dollars in millions, except par value data; shares in thousands) June 30, 2026 December 31, 2025 (unaudited) Assets Current Assets: Cash and cash equivalents $ 2,144.2 $ 4,416.9 Marketable securities 131.4 125.0 Accounts receivable, net of allowance of $ 9.1 and $ 10.0 753.1 639.2 Other current assets (includes $ 4.4 and $ 6.5 in restricted cash) 491.7 522.1 Performance bonds and guaranty fund contributions 158,110.7 159,656.1 Total current assets 161,631.1 165,359.3 Property, net of accumulated depreciation and amortization of $ 993.7 and $ 1,005.7 351.2 362.7 Intangible assets—trading products 17,175.3 17,175.3 Intangible assets—other, net 2,494.6 2,610.7 Goodwill 10,505.8 10,514.7 Other assets 2,518.6 2,401.5 Total Assets $ 194,676.6 $ 198,424.2 Liabilities and Equity Current Liabilities: Accounts payable $ 68.0 $ 71.8 Other current liabilities 538.6 568.8 Performance bonds and guaranty fund contributions 158,110.7 159,656.1 Total current liabilities 158,717.3 160,296.7 Long-term debt 3,424.2 3,422.3 Deferred income tax liabilities, net 5,220.9 5,242.2 Other liabilities 793.8 734.8 Total Liabilities 168,156.2 169,696.0 Shareholders’ Equity: Preferred stock, $ 0.01 par value, 10,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and 4,584 issued and outstanding as of December 31, 2025 — — Class A common stock, $ 0.01 par value, 1,000,000 shares authorized at June 30, 2026 and December 31, 2025; 359,275 and 358,950 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively 3.6 3.6 Class B common stock, $ 0.01 par value, 3 shares authorized, issued and outstanding as of June 30, 2026 and December 31, 2025 — — Additional paid-in capital 21,004.4 22,209.5 Retained earnings 5,457.5 6,433.2 Accumulated other comprehensive income (loss) 54.9 81.9 Total CME Group Shareholders’ Equity 26,520.4 28,728.2 Total Liabilities and Equity $ 194,676.6 $ 198,424.2 See accompanying notes to unaudited consolidated financial statements. 5 Table of Contents CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF INCOME (dollars in millions, except per share data; shares in thousands) (unaudited) Quarter Ended Six Months Ended June 30, June 30, 2026 2025 2026 2025 Revenues Clearing and transaction f